The medical transport boxes market is expected to grow at a CAGR of 7.3% during the forecast period of 2025 to 2033, driven by the increasing demand for safe and efficient transportation of medical supplies, vaccines, and pharmaceuticals. These specialized transport boxes play a crucial role in maintaining the temperature-sensitive nature of medical products during transit, ensuring their efficacy and quality. The market revenue for medical transport boxes has experienced a notable increase due to the rising global healthcare expenditure and the need for reliable cold chain logistics in pharmaceutical and biotechnology industries.
The drug discovery outsourcing market is expected to experience a CAGR of 7.5% during the forecast period of 2025 to 2033, driven by the increasing demand for efficient and cost-effective drug development processes. Drug discovery is a complex and time-consuming process that involves multiple stages, from target identification and validation to lead optimization and preclinical testing. Outsourcing these stages to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs) allows pharmaceutical companies to leverage external expertise, access cutting-edge technologies, and accelerate drug development timelines.
The barrier washer market is expected to experience a CAGR of 6% during the forecast period of 2025 to 2033. Barrier washers are specialized washing machines designed for use in healthcare facilities, pharmaceutical industries, and other environments where infection control and containment of contaminants are critical. The market revenue for Barrier Washers has been increasing due to the rising demand for infection control solutions in healthcare settings.
The air purifying escape respirators market is expected to experience a CAGR of 4.5% during the forecast period of 2025 to 2033, driven by factors such as increasing awareness about personal safety, stringent occupational safety regulations, and the need for emergency response preparedness. Air purifying escape respirators, also known as self-contained escape respirators or emergency escape respirators, are designed to provide short-term respiratory protection during emergency situations where the air is contaminated or oxygen levels are insufficient.
The sodium gluconate market is expected to experience a CAGR of 3.8% during the forecast period of 2025 to 2033, driven by its wide range of applications and favorable properties. Sodium gluconate, also known as D-gluconic acid sodium salt, is a white crystalline powder that is highly soluble in water. It is derived from glucose through a process called gluconation. The market revenue of the sodium gluconate market has been increasing as the demand for the compound grows across various industries. Sodium gluconate finds application in diverse sectors such as construction, pharmaceuticals, food and beverages, and personal care.
The single-use bioprocessing market is expected to witness a CAGR of 18% during the forecast period of 2025 to 2033, driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing processes. Single-use bioprocessing systems offer advantages such as flexibility, cost-effectiveness, reduced cross-contamination risk, and simplified cleaning and validation processes. These factors have contributed to the market's revenue growth, and the market is projected to experience a steady rise in the coming years.
The respiratory disease vaccine market is expected to witness a CAGR of 1.25% during the forecast period of 2025 to 2033, driven by the increasing prevalence of respiratory diseases and the need for effective preventive measures. Respiratory diseases, including influenza, pneumonia, and COVID-19, pose a significant global health burden, leading to high morbidity and mortality rates.
The sterilization equipment market is expected to experience a CAGR of 9.5% during the forecast period of 2025 to 2033, driven by the increasing emphasis on infection control and the rising demand for sterile medical devices and equipment in healthcare settings. Sterilization equipment plays a critical role in ensuring the elimination of microorganisms and preventing the spread of infections. These devices are used in hospitals, clinics, pharmaceutical companies, and other healthcare facilities to sterilize medical instruments, equipment, and supplies. The growth of the sterilization equipment market can be attributed to various factors.
The synthetic mentha oil market is expected to grow at a CAGR of 9.5% during the forecast period of 2025 to 2033. The synthetic mentha oil market refers to the market for artificially produced mentha oil, which is a popular flavoring and fragrance ingredient derived from the mint plant. The market has witnessed significant growth in recent years, driven by factors such as the increasing demand for mentha oil in various industries, including food and beverages, pharmaceuticals, and personal care products.
The refurbished laboratory equipment market is expected to witness a CAGR of 5% during the forecast period of 2025 to 2033, driven by the rising demand for cost-effective laboratory solutions and the increasing emphasis on sustainability and eco-friendly practices. Refurbished laboratory equipment refers to the use of laboratory instruments and devices that have been restored to a functional condition and made available for resale. These refurbished instruments offer a more affordable alternative to brand-new equipment without compromising on performance and quality.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.